We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Search
SKIP TO CONTENT
SKIP NAVIGATION
Drug & Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Publications
Webinar Training Pass
eCFR and Guidances
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
»
Authors
» Paul M. Kawamoto
Paul M. Kawamoto
Products
PRODUCTS
Philips North America, LLC
Paul M. Kawamoto
and
James R. Montero
Price:
$117.00
View
US Vascular, LLC
Paul M. Kawamoto
Price:
$117.00
View
Modus Health, LLC
Paul M. Kawamoto
Price:
$117.00
View
Mattioli Engineering Italia SpA
Paul M. Kawamoto
Price:
$117.00
View
Ziemek Dental Laboratory, Inc.
Paul M. Kawamoto
Price:
$117.00
View
Carrot Medical, LLC
Paul M. Kawamoto
Price:
$117.00
View
Sivshree Medittex (India) Pvt. Ltd.
Paul M. Kawamoto
Price:
$117.00
View
Paragon Manufacturing Corp.
Paul M. Kawamoto
Price:
$117.00
View
Orthocare Innovations, LLC
Paul M. Kawamoto
Price:
$117.00
View
Wykle, Inc.
Paul M. Kawamoto
Price:
$117.00
View
View All Products by Paul M. Kawamoto
Upcoming Events
18
Jan
A Look Ahead in 2022: Trends and Insights from Leading Experts
20
Jan
Enabling Proactive Quality Management Across Quality and Manufacturing
20
Jan
The Biden Administration’s FDA: A Remarkable 2021, What to Expect in 2022
15
Feb
Successful Strategies for Digital Health in 2022: Who’s Doing Digital Well and How You Can Get Started
16
Feb
Statistics and Data for Regulatory Professionals and Attorneys: Product Performance Evidence Made Easy
17
Feb
Gene & Cell Therapy Regulation: Comparability and Other New Developments
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
Two Models of Oscor’s Destino Twist and Guidestar Recalled
Pfizer’s Combination COVID-19 Booster and Pneumococcal Vaccine Show Promise in Late-Stage Trial
Inivata’s RaDaR Assay for Molecular Residual Disease Earns CE Mark
Takeda’s and Denali’s Alzheimer’s Drug Hit With Clinical Hold
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
